EyePoint Pharmaceuticals, Inc.

EYPT· NASDAQ· Health Care· Pharmaceuticals, Biotechnology & Life Sciences

$0.37+7.58%

2026-11-02

Financials

Valuation Metrics

EyePoint Pharmaceuticals, Inc.'s Market Cap is $32M. At end of 2025 it was $1.52B. Ranked #3093 of 3,116 in US market (top 99%), #1453 of 1,472 on NASDAQ (top 99%), #265 of 265 in Pharmaceuticals, Biotechnology & Life Sciences (top 100%) by Market Cap.

Investment Metrics(as of 2026-11-02)

Metric	Value	Rank
Size
Market Cap	$32M	US#3,093/3,116 Sec#265/265
Revenue	$3M	US#2,834/3,116 Sec#182/265
Net Income	$-307M	US—/3,116 Sec—/265
Total Assets	$228M	US#2,959/3,116 Sec#237/265
Net Assets	$166M	US#2,711/3,116 Sec#197/265
Value
P/B	0.19x	US#19/3,116 Sec#1/265
P/S	11.59x	US#2,734/3,116 Sec#123/265
FCF Yield	-839.55%	US—/3,116 Sec—/265
Profitability
ROE	-184.27%	US#2,832/3,116 Sec#216/265
Op. Margin	-11365.22%	US#2,843/3,116 Sec#184/265
Revenue Growth	-94.63%	US#2,723/3,116 Sec#180/265
Financial Health
Debt Ratio	37.12%	US#426/3,116 Sec#121/265
Total Debt	$22M	US#2,729/3,116 Sec#185/265
FCF	$-271M	US#2,835/3,116 Sec#229/265
Cash	$110M	US#2,168/3,116 Sec#166/265
Current Ratio	4.50x	US#520/3,116 Sec#156/265
Performance
1Y Return	-97.14%	US#3,126/3,116 Sec#265/265
1M Return	-88.47%	US#3,111/3,116 Sec#265/265
From 52W High	-98.04%	US#3,127/3,116 Sec#265/265
1Y MDD	-98.15%	US#3,127/3,116 Sec#265/265
Trading
Volume	5,943,572 shares	US#295/3,116 Sec#21/265
Trading Value	$2M	US#2,841/3,116 Sec#233/265
Per Share
EPS	$-3.56	US—/3,116 Sec—/265
BPS	$1.93	US#2,573/3,116 Sec#178/265